Press release
The 1,500th child supported by the Berlin Heart ventricular assist device has been transplanted
1,500th child supported by the Berlin Heart ventricular assist device has been transplanted
In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had been treated conservatively and was doing well. However his condition deteriorated at the beginning of the year so that in early June he was admitted to the Queen Mary Hospital in Hong Kong.
The LVAD implantation, to support the patient´s left ventricle, was performed by Dr. Timmy Wing-Kuk Au on the 20th of June 2014. Without the device, the boy would not have been able to wait for one of the scarce donor hearts. The recovery after the complex surgery went very well and the patient was able to do small exercises and walk around within the hospital grounds. In January, the boy´s biggest dream became true: a matching donor heart was found! The heart transplantation was performed by Dr. Au as well and the patient is now about to go home. Several patients were already treated with EXCOR® Pediatric by Dr. Au at the hospital in Hong Kong.
“We value the EXCOR® systems as it is efficient, very user friendly and it helps us to save our patients” Dr. Au summarizes the experience with the device.
This so-called artificial heart enables seriously ill children with heart defects to bridge the time until a suitable donor heart is found. It is the only system worldwide that is designed especially for the physiological needs of children.
This system was invented in Berlin and is used in children of all ages all over the world. The youngest patient that has been successfully supported with this device was just twelve days old.
„We are very happy to see that the 1500th patient could be successfully bridged to transplantation with our device. Our goal is to save critically ill patients worldwide with our systems” says Dr. Ares K. Menon, General Manager of the Berlin Heart GmbH.
About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The devices INCOR®, EXCOR® Adult and EXCOR® Pediatric can support failing hearts short-, mid- and long-term and therefore offer a life-saving therapy. Customers moreover benefit from clinical and technical support by Berlin Heart VAD specialists who are available 24/7. INCOR® and EXCOR® Adult are not FDA-approved, but widely used in Europe.
About EXCOR®
EXCOR® is a paracorporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 3,600 patients worldwide.
The Berlin Heart EXCOR® Pediatric Ventricular Assist Device (EXCOR® Pediatric) is approved for use by the FDA under a Humanitarian Device Exemption. All other products are unavailable in the US.
Berlin Heart GmbH
Wiesenweg 10
12247 Berlin
www.berlinheart.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The 1,500th child supported by the Berlin Heart ventricular assist device has been transplanted here
News-ID: 309864 • Views: …
More Releases from Berlin Heart
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed.
The clinics in Spain benefit from an excellent service by Palex Medical…
More Releases for EXCOR®
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed.
The clinics in Spain benefit from an excellent service by Palex Medical…
1. Japanese EXCOR® Pediatric patient successfully transplanted
Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected.
In August 2012, for the first time in Japan’s history, it was possible…
Longest support time with the EXCOR® Pediatric ventricular assist device
Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world.
The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago.
In February 2010 Lara was in…
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled.
The study, which enrolled the first patient in November 2007, is the first prospective clinical…
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled.
The study, which enrolled the first patient in November 2007,…
Successful transatlantic EXCOR® air ambulance transportations
Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months.
The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.…
